Vertical Longevity Pharmaceuticals

📍 Irvine, United States🗓 Founded 2024👥 3 employees💰 Last funded Nov 2025
Biotechnology Research🌐 vertical-longevity-pharma.com
Website LinkedIn
At Vertical Longevity Pharma, were harnessing the power of virus-like particle (VLP) vaccines to eliminate senescent cells, one of the fundamental drivers of aging and chronic disease. Preclinical senescent cell clearance has demonstrated therapeutic benefits across every organ system investigated, including curative potential for atherosclerosis, the world’s leading cause of death. Engineered for stability at room temperature, our immunotherapy can remove the need for cold-chain logistics, enabling global accessibility and scalability even in low-resource settings. If you share our vision for extending healthy human lifespan or have a personal connection to heart disease, you can now become part of this mission. Low barrier to entry and no investor accreditation required: 👉 https://netcapital.com/companies/vertical-longevity
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Vertical Longevity Pharmaceuticals?
Vertical Longevity Pharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Vertical Longevity Pharmaceuticals last raise funding?
The most recent investment in Vertical Longevity Pharmaceuticals recorded on gritt.io was in November 2025.
When was Vertical Longevity Pharmaceuticals founded?
Vertical Longevity Pharmaceuticals was founded in 2024.
What industry is Vertical Longevity Pharmaceuticals in?
Vertical Longevity Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vertical Longevity Pharmaceuticals based?
Vertical Longevity Pharmaceuticals is headquartered in Irvine, United States.